Charite University Hospital, Berlin – Germany
About Prof. Dr. Jalid Sehouli
Prof. Dr. Dr. h.c. Jalid Sehouli is a globally renowned Gynaecologist and Gynaecological Oncologist with over 25 years of experience and a W3 lifetime professorship at Charité, Berlin. He is internationally regarded as one of the best Gynaecology and Gynaecological Oncology doctors in Germany, particularly for ovarian, fallopian tube, and peritoneal cancers.
- 25+ years of clinical experience in Gynaecology and Gynaecological Oncology
- Director, Department of Gynecology with Center for Oncological Surgery, Charité — Universitätsmedizin Berlin
- 700+ peer-reviewed publications in international journals
- Founder, German Ovarian Cancer Foundation
- Recipient of the Roma Focus Award (2015) and Moroccan Royal Order of Merit (2016)
- Author of multiple books including "On the Art of Breaking Bad News Well"
Qualifications & Credentials
Medical Degrees
- Medical Studies (MD / Graduation) — Freie Universität Berlin, Germany, 1989–1995
- Doctorate (Dr. med.) — Charité, 1998 (Thesis: Postoperative Use of Unconventional Cancer Therapies in Gynaecological Oncology)
- Habilitation in Gynaecology — Humboldt-Universität zu Berlin, Germany, 2005 (Thesis: Multimodal Management of Malignant Ovarian Tumours)
- MBA / Diploma in Business Management — Health Economics, Business University of Ural, 2005–2006
- Honorary Doctorate (Dr. h.c.)
Fellowships & Special Training
- Specialist Certification in Gynaecology & Obstetrics — Charité Berlin, 2002
- Special Training — Gynaecological Oncology, 2006
- Certification — Student Teaching, Gynaecology and Obstetrics, 2005
Certifications & Accreditations
- German Medical Council Registration (Berlin)
- W3 Tenured Full Professor of Gynaecology — Charité, since 2014
- Member — European Society of Gynaecological Oncology (ESGO) — Prevention Committee
- Member — Gynecologic Cancer InterGroup (GCIG) — Official German Member
- Member — American Society of Clinical Oncology (ASCO)
- Member — International Gynecologic Cancer Society (IGCS)
- President — Berlin Society of Gynecology and Obstetrics
Areas of Expertise
Major Conditions Treated
- Ovarian Cancer (Ovarian Carcinoma) — Special Focus
- Fallopian Tube Cancer (Tubal Carcinoma)
- Peritoneal Cancer (Peritoneal Carcinoma)
- Endometrial / Uterine Cancer
- Cervical Cancer
- Vulvar & Vaginal Cancer
- Gynaecological Sarcoma
- Recurrent Gynaecological Cancers
- Hereditary Gynaecological Cancers (BRCA-positive)
- Endometriosis
- Uterine Fibroids
Sub-specialties
- Ovarian Cancer Surgery & Cytoreduction: Internationally recognised authority on cytoreductive (debulking) surgery for advanced ovarian cancer — a leading Gynaecology specialist in Berlin, Germany.
- Robot-Assisted & Minimally Invasive Tumour Surgery: Specialist in keyhole and robot-assisted gynaecological cancer surgery — recognised among the best Gynaecology doctors in Germany.
- Clinical Trials & Targeted Therapy: Lead investigator of multiple Phase I, II, and III studies on PARP inhibitors, HSP90 inhibitors, and immunotherapy in ovarian cancer.
Advanced Procedures & Treatments
- Cytoreductive (Debulking) Surgery for Advanced Ovarian Cancer
- Radical Multivisceral Surgery
- Robot-Assisted Gynaecological Cancer Surgery
- Laparoscopic Hysterectomy & Lymph Node Dissection
- Radical Hysterectomy for Cervical Cancer
- HIPEC (Hyperthermic Intraperitoneal Chemotherapy)
- Targeted Therapy with PARP Inhibitors (e.g., Olaparib, Rucaparib)
- Chemotherapy & Immunotherapy Protocols
- Opportunistic Salpingectomy for Ovarian Cancer Prevention
- Prehabilitation Programmes for Cancer Surgery
List of Disease and Treatment for which Prof. Dr. Jalid Sehouli can be consulted
Professional Experience
Current Affiliation
- Charité — Universitätsmedizin Berlin, Berlin, Germany — Director, Department of Gynecology with Center for Oncological Surgery (Campus Virchow Klinikum); Director, Department of Gynaecology (Campus Benjamin Franklin) (Present)
- Charité — Universitätsmedizin Berlin, Berlin, Germany — Head, European Competence Center for Ovarian Cancer (EKZE); Head, Gynaecological Tumor Center; Co-Director, Charité Comprehensive Cancer Center (CCCC) (Present)
- Humboldt University of Berlin / Charité, Germany — W3 Tenured Full Professor for Life, since 2014 (Present)
Past Affiliations
- Charité — Universitätsmedizin Berlin, Germany — W2 Professor of Gynaecology, 2007–2014
- Charité — Universitätsmedizin Berlin, Germany — Senior Consultant (Oberarzt) and Consultant of Gynaecology & Obstetrics, 1999–2002
- Charité — Universitätsmedizin Berlin, Germany — Postgraduate trainee in Gynaecology & Obstetrics, until 1998
Academic & Research Roles
- Co-Director — Charité Comprehensive Cancer Center (CCCC)
- Senior Editor — International Journal of Gynecological, Obstetrical, and Reproductive Medicine Research
- Co-Editor — Archives of Gynecology and Obstetrics
- Founder — German Ovarian Cancer Foundation
- Founder — "DIWA" and "Rosi" patient communities; European Artists' Guild for Medicine and Culture
- Author of 700+ peer-reviewed publications and 50+ book chapters
Key Achievements
- 25+ years of dedicated experience in Gynaecology and Gynaecological Oncology
- W3 Tenured Lifetime Professorship at Charité (since 2014) — one of Germany's highest academic positions
- Director of one of Europe's largest gynaecological oncology centres
- 700+ peer-reviewed scientific publications
- Founder of the German Ovarian Cancer Foundation
- Author of widely cited books on doctor-patient communication and creative writing for cancer patients
Awards & Recognitions
National & International Awards
- Roma Focus Award — 2015 (for contributions to gynaecological oncology)
- Moroccan Royal Order of Merit — 2016 (awarded by King Mohammed VI)
- Diwan Award, Germany — 2017
- Cultures of Peace Award, Paris — 20 December 2019
- Honorary Doctorate (Dr. h.c.)
Professional Memberships
- European Society of Gynaecological Oncology (ESGO) — Prevention Committee
- Gynecologic Cancer InterGroup (GCIG) — Official German Member
- American Society of Clinical Oncology (ASCO)
- International Gynecologic Cancer Society (IGCS)
- North-Eastern German Society of Gynaecological Oncology (NOGGO) — Board Member & Secretary
- Berlin Society of Gynecology and Obstetrics — President
Research & Publications
Published Papers (Selected)
- Sehouli J, et al. "Impact of rucaparib on circadian rhythms and adverse events in ovarian cancer: Insights from the MAMOC trial." Multiple peer-reviewed publications in major journals.
- Sehouli J, et al. "Risk factors for anastomotic leakage and its impact on survival outcomes in radical multivisceral surgery for advanced ovarian cancer: an AGO-OVAR.OP3/LION exploratory analysis."
- Intergroup statement: opportunistic salpingectomy — molecular pathology, clinical outcomes and implications for practice (German Ovarian Cancer Commission, NOGGO, AGO Austria, AGO Swiss).
- Author of more than 700 international publications in specialist journals and editor of multiple regular publications.
Ongoing Research & Clinical Interests
- Targeted therapy and PARP inhibitors in ovarian cancer
- Cytoreductive surgery for advanced ovarian malignancy
- Patient-centred outcomes and quality of life in gynaecological cancer
- Clinical health services research in oncology
- Doctor-patient communication and breaking bad news
- Global Health and gynaecological oncology in the MENA region (PARSGO)
Estimated Treatment Costs
| Procedure / Consultation | Estimated Cost (EUR) | Estimated Cost (USD) |
|---|---|---|
| Gynaecological Oncology Consultation | €300 – €600 | $325 – $650 |
| Robotic Radical Hysterectomy | €18,000 – €32,000 | $19,500 – $34,500 |
| Cytoreductive (Debulking) Surgery for Ovarian Cancer | €25,000 – €50,000 | $27,000 – $54,000 |
| Radical Multivisceral Surgery (Advanced Ovarian Cancer) | €35,000 – €70,000 | $38,000 – $76,000 |
| HIPEC for Peritoneal Carcinoma | €30,000 – €55,000 | $32,500 – $59,500 |
| Chemotherapy (per cycle) | €2,000 – €8,000 | $2,150 – $8,650 |
| PARP Inhibitor Therapy (per month) | €5,000 – €12,000 | $5,400 – $13,000 |
*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.
Frequently Asked Questions
1. What advanced technologies does Prof. Dr. Dr. h.c. Jalid Sehouli use in Gynaecology and Gynaecological Oncology treatment?
Prof. Dr. Dr. h.c. Jalid Sehouli employs the latest evidence-based tools and minimally invasive techniques relevant to Gynaecology and Gynaecological Oncology. Virtual consultations and remote second opinions are also available to international patients. Contact Cancer Rounds for a detailed technology overview specific to your case.
2. What conditions does Prof. Dr. Dr. h.c. Jalid Sehouli specialize in treating?
Prof. Dr. Dr. h.c. Jalid Sehouli is a specialist in Gynaecology and Gynaecological Oncology, treating a broad spectrum of conditions in this field — including both common presentations and complex, rare cases. International patients seek treatment for conditions requiring expert Gynaecology and Gynaecological Oncology care in Berlin, Germany.
3. How do I book an appointment with Prof. Dr. Dr. h.c. Jalid Sehouli?
Appointments with Prof. Dr. Dr. h.c. Jalid Sehouli can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.
4. Can international patients receive treatment from Prof. Dr. Dr. h.c. Jalid Sehouli?
Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Prof. Dr. Dr. h.c. Jalid Sehouli, including medical visa invitation letters, airport transfers, and local accommodation coordination.
5. What support is available for international patients?
International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation, financial counselling, and pre-travel virtual consultations to review medical records before arrival.
6. Does Prof. Dr. Dr. h.c. Jalid Sehouli offer second opinions for Gynaecology and Gynaecological Oncology cases?
Yes. Second opinion consultations can be arranged via Cancer Rounds for patients who wish to review their diagnosis or treatment plan with an expert Gynaecology and Gynaecological Oncology specialist in Berlin, Germany.
Ovarian Cancer
